KNSA vs MSFT: Which Stock is Better?
Side-by-side comparison of Kiniksa Pharmaceuticals Ltd and Microsoft Corporation in 2026
KNSA
Kiniksa Pharmaceuticals Ltd
$79.40
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | KNSA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $3.73B | $3.71T | MSFT |
| P/E Ratio | 91.38 | 33.89 | MSFT |
| EPS (TTM) | $0.45 | $14.08 | MSFT |
| Revenue Growth | 61.2% | 18.4% | KNSA |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze KNSA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KNSA or MSFT a better investment?
Comparing KNSA and MSFT: Kiniksa Pharmaceuticals Ltd has a market cap of $3.73B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KNSA and MSFT?
KNSA (Kiniksa Pharmaceuticals Ltd) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KNSA or MSFT?
Based on P/E ratios, MSFT trades at a lower multiple (33.9x vs 91.4x).
Which is growing faster: KNSA or MSFT?
KNSA has higher revenue growth at 61.2% vs 18.4% for MSFT.
Which company is more profitable: KNSA or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for KNSA.
Which is the larger company: KNSA or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $3.73B for KNSA.
Should I buy KNSA or MSFT in 2026?
Both KNSA and MSFT have investment merit. KNSA trades at $79.40 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KNSA and MSFT stock?
Key differences: Market Cap ($3.73B vs $3.71T), P/E Ratio (91.4x vs 33.9x), Revenue Growth (61.2% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy KNSA or MSFT in 2026?
The choice between KNSA and MSFT depends on your investment goals. KNSA shows higher revenue growth (61.2%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between KNSA and MSFT?
KNSA (Kiniksa Pharmaceuticals Ltd) has a market cap of $3.73B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.